Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

A multicenter study of the real-world use of ceftaroline versus vancomycin for acute bacterial skin and skin structure infections.

Trinh TD, Jorgensen SCJ, Zasowski EJ, Claeys KC, Lagnf AM, Estrada SJ, Delaportes DJ, Huang V, Klinker KP, Kaye KS, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01007-19. doi: 10.1128/AAC.01007-19. [Epub ahead of print]

PMID:
31405859
2.

Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus.

Claeys KC, Zasowski EJ, Trinh TD, Casapao AM, Pogue JM, Bhatia N, Mynatt RP, Wilson SS, Arthur C, Welch R, Sherwin R, Hafeez W, Levine DP, Kaye KS, Delgado G, Giuliano CA, Takla R, Rieck C, Johnson LB, Murray KP, Gordon J, Reyes K, Hartman P, Davis SL, Rybak MJ.

Infect Dis Ther. 2019 Jun;8(2):199-208. doi: 10.1007/s40121-019-0242-5. Epub 2019 Mar 27.

3.

Advances and Challenges in the Diagnosis and Treatment of Urinary Tract Infections: the Need for Diagnostic Stewardship.

Claeys KC, Blanco N, Morgan DJ, Leekha S, Sullivan KV.

Curr Infect Dis Rep. 2019 Mar 5;21(4):11. doi: 10.1007/s11908-019-0668-7. Review.

PMID:
30834993
4.

Validation of an Antimicrobial Stewardship-Driven Verigene Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics.

Claeys KC, Schlaffer KE, Heil EL, Leekha S, Johnson JK.

Open Forum Infect Dis. 2018 Sep 15;5(10):ofy233. doi: 10.1093/ofid/ofy233. eCollection 2018 Oct.

5.

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study.

Gallagher JC, Satlin MJ, Elabor A, Saraiya N, McCreary EK, Molnar E, El-Beyrouty C, Jones BM, Dixit D, Heil EL, Claeys KC, Hiles J, Vyas NM, Bland CM, Suh J, Biason K, McCoy D, King MA, Richards L, Harrington N, Guo Y, Chaudhry S, Lu X, Yu D.

Open Forum Infect Dis. 2018 Oct 31;5(11):ofy280. doi: 10.1093/ofid/ofy280. eCollection 2018 Nov.

6.

Making the change to area under the curve-based vancomycin dosing.

Heil EL, Claeys KC, Mynatt RP, Hopkins TL, Brade K, Watt I, Rybak MJ, Pogue JM.

Am J Health Syst Pharm. 2018 Dec 15;75(24):1986-1995. doi: 10.2146/ajhp180034. Epub 2018 Oct 17. No abstract available.

PMID:
30333114
7.

Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare Setting.

Claeys KC, Zasowski EJ, Lagnf AM, Sabagha N, Levine DP, Davis SL, Rybak MJ.

Infect Dis Ther. 2018 Dec;7(4):495-507. doi: 10.1007/s40121-018-0212-3. Epub 2018 Sep 22.

8.

Pharmacokinetic and Pharmacodynamic Considerations of Antibiotics of Last Resort in Treating Gram-Negative Infections in Adult Critically Ill Patients.

Heavner MS, Claeys KC, Masich AM, Gonzales JP.

Curr Infect Dis Rep. 2018 Apr 5;20(5):10. doi: 10.1007/s11908-018-0614-0. Review.

PMID:
29623443
9.

Pharmacokinetic/Pharmacodynamic Considerations of Beta-Lactam Antibiotics in Adult Critically Ill Patients.

Masich AM, Heavner MS, Gonzales JP, Claeys KC.

Curr Infect Dis Rep. 2018 Apr 4;20(5):9. doi: 10.1007/s11908-018-0613-1. Review.

PMID:
29619607
10.

Fluoroquinolone Restriction as an Effective Antimicrobial Stewardship Intervention.

Claeys KC, Hopkins TL, Vega AD, Heil EL.

Curr Infect Dis Rep. 2018 Mar 23;20(5):7. doi: 10.1007/s11908-018-0615-z. Review.

PMID:
29572691
11.

An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two Cities.

Pogue JM, Heil EL, Lephart P, Johnson JK, Mynatt RP, Salimnia H, Claeys KC.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02538-17. doi: 10.1128/AAC.02538-17. Print 2018 May.

12.

Role of Vancomycin Minimum Inhibitory Concentrations by Modified Population Analysis Profile Method and Clinical Outcomes in High Inoculum Methicillin-Resistant Staphylococcus aureus Infections.

Trinh TD, Zasowski EJ, Claeys KC, Casapao AM, Compton M, Lagnf A, Kidambi SD, Levine DP, Rybak MJ.

Infect Dis Ther. 2018 Mar;7(1):161-169. doi: 10.1007/s40121-018-0187-0. Epub 2018 Feb 22.

13.

The Verigene dilemma: gram-negative polymicrobial bloodstream infections and clinical decision making.

Claeys KC, Heil EL, Pogue JM, Lephart PR, Johnson JK.

Diagn Microbiol Infect Dis. 2018 Jun;91(2):144-146. doi: 10.1016/j.diagmicrobio.2018.01.012. Epub 2018 Feb 2.

PMID:
29449043
14.

Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis.

Claeys KC, Zasowski EJ, Trinh TD, Lagnf AM, Davis SL, Rybak MJ.

Infect Dis Ther. 2018 Mar;7(1):135-146. doi: 10.1007/s40121-017-0179-5. Epub 2017 Nov 21.

15.

Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.

Smith JR, Frens JJ, Snider CB, Claeys KC.

Diagn Microbiol Infect Dis. 2018 Jan;90(1):50-54. doi: 10.1016/j.diagmicrobio.2017.10.001. Epub 2017 Oct 7.

PMID:
29153470
16.

Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors.

Trinh TD, Zasowski EJ, Claeys KC, Lagnf AM, Kidambi S, Davis SL, Rybak MJ.

Diagn Microbiol Infect Dis. 2017 Sep;89(1):61-66. doi: 10.1016/j.diagmicrobio.2017.06.009. Epub 2017 Jun 19.

PMID:
28716451
17.

Novel application of published risk factors for methicillin-resistant S. aureus in acute bacterial skin and skin structure infections.

Claeys KC, Zasowski EJ, Lagnf AM, Levine DP, Davis SL, Rybak MJ.

Int J Antimicrob Agents. 2018 Jan;51(1):43-46. doi: 10.1016/j.ijantimicag.2017.05.015. Epub 2017 Jun 28.

PMID:
28668679
18.

Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Zasowski EJ, Trinh TD, Claeys KC, Casapao AM, Sabagha N, Lagnf AM, Klinker KP, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02015-16. doi: 10.1128/AAC.02015-16. Print 2017 Feb.

19.

Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Claeys KC, Zasowski EJ, Casapao AM, Lagnf AM, Nagel JL, Nguyen CT, Hallesy JA, Compton MT, Kaye KS, Levine DP, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5841-8. doi: 10.1128/AAC.00227-16. Print 2016 Oct.

20.

Comparison of clinical outcomes and risk factors in polymicrobial versus monomicrobial enterococcal bloodstream infections.

Lagnf AM, Zasowski EJ, Claeys KC, Casapao AM, Rybak MJ.

Am J Infect Control. 2016 Aug 1;44(8):917-21. doi: 10.1016/j.ajic.2016.02.017. Epub 2016 Apr 11.

PMID:
27079241
21.

Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections.

Zasowski EJ, Claeys KC, Lagnf AM, Davis SL, Rybak MJ.

Clin Infect Dis. 2016 May 15;62(10):1242-1250. doi: 10.1093/cid/ciw110. Epub 2016 Mar 3.

22.

Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter?

Claeys KC, Lagnf AM, Hallesy JA, Compton MT, Gravelin AL, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2016 Jan 4;60(3):1708-16. doi: 10.1128/AAC.02388-15.

23.

Comparison of outcomes between patients with single versus multiple positive blood cultures for Enterococcus: Infection versus illusion?

Claeys KC, Zasowski EJ, Lagnf AM, Rybak MJ.

Am J Infect Control. 2016 Jan 1;44(1):47-9. doi: 10.1016/j.ajic.2015.08.002. Epub 2015 Sep 19.

PMID:
26388037
24.

Acute Bacterial Skin and Skin Structure Infections Treated with Intravenous Antibiotics in the Emergency Department or Observational Unit: Experience at the Detroit Medical Center.

Claeys KC, Lagnf AM, Patel TB, Jacob MG, Davis SL, Rybak MJ.

Infect Dis Ther. 2015 Jun;4(2):173-86. doi: 10.1007/s40121-015-0069-7. Epub 2015 Jun 9.

25.

Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis.

Casapao AM, Lodise TP, Davis SL, Claeys KC, Kullar R, Levine DP, Rybak MJ.

Antimicrob Agents Chemother. 2015;59(6):2978-85. doi: 10.1128/AAC.03970-14. Epub 2015 Mar 9.

26.

Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.

Claeys KC, Smith JR, Casapao AM, Mynatt RP, Avery L, Shroff A, Yamamura D, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2015 Apr;59(4):1969-76. doi: 10.1128/AAC.04141-14. Epub 2015 Jan 20.

27.

A Review of Novel Combinations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii.

Claeys KC, Fiorvento AD, Rybak MJ.

Infect Dis Ther. 2014 Dec;3(2):69-81. doi: 10.1007/s40121-014-0051-9. Epub 2014 Dec 5. Review.

28.

High-dose daptomycin therapy for staphylococcal endocarditis and when to apply it.

Smith JR, Claeys KC, Barber KE, Rybak MJ.

Curr Infect Dis Rep. 2014 Oct;16(10):429. doi: 10.1007/s11908-014-0429-6.

Supplemental Content

Loading ...
Support Center